Febrile neutropenia in patients treated with chemotherapy/immune checkpoint inhibition: a MASCC consensus statement.
Saved in:
| Title: | Febrile neutropenia in patients treated with chemotherapy/immune checkpoint inhibition: a MASCC consensus statement. |
|---|---|
| Authors: | Cooksley T; The Christie NHS Trust, Manchester, UK. cooks199@hotmail.com.; University of Greater Manchester, Bolton, UK. cooks199@hotmail.com., Font C; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona, Spain., Thursky K; Peter Maccallum Cancer Centre, Melbourne, Australia., Rapoport B; Medical Oncology Centre of Rosebank, Johannesburg, South Africa., Falandry C; Hopital Lyon Sud, Université Claude Bernard Lyon 1, Pierre Benite, France., Scotte F; Gustave Roussy, Villejuif, France. |
| Source: | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2026 Jul 29; Vol. 34 (8). Date of Electronic Publication: 2026 Jul 29. |
| Publication Type: | Journal Article; Consensus Statement; Review |
| Journal Info: | Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
